Pubblicazioni

Renna LV, Bertani F, Podio A, Boveri S, Carrara M, Pinton A, Milani V, Spuria G, Nizza AF, Basilico S, et al (2023): Impact of BNT162b2 Booster Dose on SARS-CoV-2 Anti-Trimeric Spike Antibody Dynamics in a Large Cohort of Italian Health Care Workers. Vaccines; 11: 463.

Šušnjar U, Škrabar N, Brown AL, Abbassi Y, Phatnani H; NYGC ALS Consortium; Cortese A, Cereda C, Bugiardini E, Cardani R, Meola G, Ripolone M, Moggio M, Romano M, Secrier M, Fratta P, Buratti E. Cell environment shapes TDP-43 function with implications in neuronal and muscle disease. Commun Biol. 2022 Apr 5;5(1):314. doi: 10.1038/s42003-022-03253-8. PMID: 35383280; PMCID: PMC8983780.

Malavazos AE, Basilico S, Iacobellis G, Milani V, Cardani R, Boniardi F,Dubini C, Prandoni I, Capitanio G, Renna LV, Boveri S, Rigolini R, Carrara M, Spuria G, Cuppone T, D’acquisto A, Carpinelli L, Sacchi M, Morricone L, Secchi F, Costa E, Menicanti L, Nisoli E, Carruba M, Ambrogi F, Corsi Romanelli MM. Antibody responses to BNT162b2 mRNA vaccine: Infection-naïve individuals with abdominal obesity warrant attention. Obesity (Silver Spring). 2022 Mar;30(3):606-613. doi: 10.1002/oby.23353. Epub 2022 Feb 11. PMID: 34850576.

Mazzaccaro D, Dolci M, Perego F, Delbue S, Giannetta M, Cardani R, Valentina Renna L, Costa E, Corsi-Romanelli MM, Galli C, Pariani E, Nano G, Clemente C, Basilico N. Viral Agents and Systemic Levels of Inflammatory Cytokines in Vulnerable and Stable Atherosclerotic Carotid Plaques. Ann Vasc Surg. 2021 Dec 11:S0890-5096(21)00912-2. doi: 10.1016/j.avsg.2021.10.070. Epub ahead of print. PMID: 34902464.

Locci S, Cardani R, Brunori P, Lucchiari S, Comi GP, Federico A, De Stefano N, Meola G, Mignarri A. Co-occurrence of DMPK expansion and CLCN1 mutation in a patient with myotonia. Neurol Sci. 2021 Dec;42(12):5365-5368. doi: 10.1007/s10072-021-05538-y. Epub 2021 Aug 13. PMID: 34386887.

Cavalli M, Cardani R, Renna LV, Toffetti M, Villa L, Meola G. First Family of MATR3-Related Distal Myopathy From Italy: The Role of Muscle Biopsy in the Diagnosis and Characterization of a Still Poorly Understood Disease. Front Neurol. 2021 Oct 1;12:715386. doi: 10.3389/fneur.2021.715386. PMID: 34659085;PMCID: PMC8517147.

Botta A, Visconti VV, Fontana L, Bisceglia P, Bengala M, Massa R, Bagni I, Cardani R, Sangiuolo F, Meola G, Antonini G, Petrucci A, Pegoraro E, D’Apice MR, Novelli G. A 14-Year Italian Experience in DM2 Genetic Testing: Frequency and Distribution of Normal and Premutated CNBP Alleles. Front Genet. 2021 Jun 21;12:668094. doi: 10.3389/fgene.2021.668094. PMID: 34234810; PMCID: PMC8255792.

Sitzia C, Pistelli L, Cardani R, Renna LV, Ranucci M, Carrara M, Borlini S, Clerici P, Rampoldi B, Cornetta M, Corsi-Romanelli M. Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter? J Biol Regul Homeost Agents. 2021 May-Jun;35(3):881-887. doi: 10.23812/21-163-A. PMID: 34231353.

Dozio E, Sitzia C, Pistelli L, Cardani R, Rigolini R, Ranucci M, Corsi Romanelli MM. Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers. J Clin Med. 2020 Nov 23;9(11):3785. doi:10.3390/jcm9113785. PMID: 33238596; PMCID: PMC7700384.

Cardani R, Bertoldo EG, Cerri A, Picozzi M, Corsi Romanelli MM, Callus E. Establishment of a cardiac biobank in a Department of Pathology and Laboratory Medicine. J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6):1983-1991. doi: 10.23812/20-158-R. PMID: 33426856.

Ranucci M, Sitzia C, Baryshnikova E, Di Dedda U, Cardani R, Martelli F, Corsi Romanelli M. Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome. J Clin Med. 2020 Oct 28;9(11):3487. doi: 10.3390/jcm9113487. PMID: 33126772; PMCID: PMC7692774.

Alì M, Monti CB, Melazzini L, Cardani R, Fossati B, Cavalli M, Chow K, Secchi F, Meola G, Sardanelli F. Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1. Front Neurol. 2020 Mar 19;11:192. doi: 10.3389/fneur.2020.00192. PMID: 32265828; PMCID: PMC7098463.

Bosè F, Renna LV, Fossati B, Arpa G, Labate V, Milani V, Botta A, Micaglio E, Meola G, Cardani R. TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2. Front Neurol. 2019 Sep 27;10:992. doi: 10.3389/fneur.2019.00992. PMID: 31611837;PMCID: PMC6776629.

Bachmann C, Noreen F, Voermans NC, Schär PL, Vissing J, Fock JM, Bulk S, Kusters B, Moore SA, Beggs AH, Mathews KD, Meyer M, Genetti CA, Meola G, Cardani R, Mathews E, Jungbluth H, Muntoni F, Zorzato F, Treves S. Aberrant regulation of epigenetic modifiers contributes to the pathogenesis in patients with selenoprotein N-related myopathies. Hum Mutat. 2019 Jul;40(7):962-974. doi: 10.1002/humu.23745. Epub 2019 Apr 1. PMID: 30932294; PMCID: PMC6660981.

Voellenkle C, Perfetti A, Carrara M, Fuschi P, Renna LV, Longo M, Sain SB, Cardani R, Valaperta R, Silvestri G, Legnini I, Bozzoni I, Furling D, Gaetano C, Falcone G, Meola G, Martelli F. Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1. Int J Mol Sci. 2019 Apr 19;20(8):1938. doi: 10.3390/ijms20081938. PMID: 31010208; PMCID: PMC6515344.

Renna LV, Bosè F, Brigonzi E, Fossati B, Meola G, Cardani R. Aberrantnsulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies. PLoS One. 2019 Mar 22;14(3):e0214254.doi: 10.1371/journal.pone.0214254. PMID: 30901379; PMCID: PMC6430513.

Callus E, Bertoldo EG, Beretta M, Boveri S, Cardani R, Fossati B, Brigonzi E, Meola G. Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy. Front Neurol. 2018 Sep 19;9:751. doi:10.3389/fneur.2018.00751. PMID: 30298045; PMCID: PMC6160752.

Altamura C, Lucchiari S, Sahbani D, Ulzi G, Comi GP, D’Ambrosio P, Petillo R, Politano L, Vercelli L, Mongini T, Dotti MT, Cardani R, Meola G, Lo Monaco M, Matthews E, Hanna MG, Carratù MR, Conte D, Imbrici P, Desaphy JF. The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel. Hum Mutat. 2018 Sep;39(9):1273-1283. doi: 10.1002/humu.23581. Epub 2018 Jul 4. PMID:29935101.

De Siena C, Cardani R, Brigonzi E, Bosè F, Fossati B, Meola G, Costa E, Valaperta R. Incidence of amplification failure in DMPK allele due to allelic dropout event in a diagnostic laboratory. Clin Chim Acta. 2018 Sep;484:111-116 doi: 10.1016/j.cca.2018.05.040. Epub 2018 May 24. PMID: 29803895.

Binda A, Renna LV, Bosè F, Brigonzi E, Botta A, Valaperta R, Fossati B, Rivolta I, Meola G, Cardani R. SCN4A as modifier gene in patients with myotonic dystrophy type 2. Sci Rep. 2018 Jul 23;8(1):11058. doi:10.1038/s41598-018-29302-z. PMID: 30038349; PMCID: PMC6056531.

Cappella M, Perfetti A, Cardinali B, Garcia-Manteiga JM, Carrara M, Provenzano C, Fuschi P, Cardani R, Renna LV, Meola G, Falcone G, Martelli F. High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2. Cell Death Dis. 2018 Jun 28;9(7):729. doi: 10.1038/s41419-018-0769-5. PMID: 29955039; PMCID: PMC6023919.

Cavalli M, Fossati B, Vitale R, Brigonzi E, Ricigliano VAG, Saraceno L, Cardani R, Pappone C, Meola G. Flecainide-Induced Brugada Syndrome in a Patient With Skeletal Muscle Sodium Channelopathy: A Case Report With Critical Therapeutical Implications and Review of the Literature. Front Neurol. 2018 May 30;9:385. doi: 10.3389/fneur.2018.00385. PMID: 29899727; PMCID: PMC5988887.

Provenzano C, Cappella M, Valaperta R, Cardani R, Meola G, Martelli F,Cardinali B, Falcone G. CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients. Mol Ther Nucleic Acids. 2017 Dec 15;9:337-348. doi: 10.1016/j.omtn.2017.10.006. Epub 2017 Oct 14. PMID: 29246312; PMCID: PMC5684470.

Valaperta R, De Siena C, Cardani R, Lombardia F, Cenko E, Rampoldi B, Fossati B, Brigonzi E, Rigolini R, Gaia P, Meola G, Costa E, Bugiardini R.Cardiac involvement in myotonic dystrophy: The role of troponins and N-terminal pro B-type natriuretic peptide. Atherosclerosis. 2017 Dec;267:110-115. doi:10.1016/j.atherosclerosis.2017.10.020. Epub 2017 Oct 21. PMID: 29121498.

Dozio E, Passeri E, Cardani R, Benedini S, Aresta C, Valaperta R, Corsi Romanelli M, Meola G, Sansone V, Corbetta S. Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic Dystrophies. Front Endocrinol (Lausanne). 2017 Nov 14;8:320. doi: 10.3389/fendo.2017.00320. PMID: 29184538;PMCID: PMC5694592.

Renna LV, Bosè F, Iachettini S, Fossati B, Saraceno L, Milani V, Colombo R, Meola G, Cardani R. Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle. PLoS One. 2017 Sep 15;12(9):e0184987. doi: 10.1371/journal.pone.0184987. PMID: 28915272; PMCID: PMC5600405.

Meola G, Biasini F, Valaperta R, Costa E, Cardani R. Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach. J Neurol. 2017 Aug;264(8):1705-1714. doi: 10.1007/s00415-017-8504-1. Epub 2017 May 26. PMID:28550479.

Meola G, Cardani R. Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects. Neurol Sci. 2017 Apr;38(4):535-546. doi:10.1007/s10072-016-2805-5. Epub 2017 Jan 11. PMID: 28078562.

Perfetti A, Greco S, Cardani R, Fossati B, Cuomo G, Valaperta R, Ambrogi F, Cortese A, Botta A, Mignarri A, Santoro M, Gaetano C, Costa E, Dotti MT, Silvestri G, Massa R, Meola G, Martelli F. Erratum: Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1. Sci Rep. 2017 Feb 22;7:43074. doi: 10.1038/srep43074. Erratum for: Sci Rep. 2016 Dec 01;6:38174. PMID: 28225046; PMCID: PMC5320479.

Valaperta R, Gaeta M, Cardani R, Lombardi F, Rampoldi B, De Siena C, Mori F,Fossati B, Gaia P, Ferraro OE, Villani S, Iachettini S, Piccoli M, Cirillo F,Pusineri E, Meola G, Costa E. High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy: A case-controlstudy. Clin Chim Acta. 2016 Dec 1;463:122-128. doi: 10.1016/j.cca.2016.10.026.Epub 2016 Oct 22. PMID: 27780717.

Vono R, Fuoco C, Testa S, Pirrò S, Maselli D, Ferland McCollough D, Sangalli E, Pintus G, Giordo R, Finzi G, Sessa F, Cardani R, Gotti A, Losa S, Cesareni G, Rizzi R, Bearzi C, Cannata S, Spinetti G, Gargioli C, Madeddu P. Activation of the Pro-Oxidant PKCβII-p66Shc Signaling Pathway Contributes to Pericyte Dysfunction in Skeletal Muscles of Patients With Diabetes With Critical Limb Ischemia. Diabetes. 2016 Dec;65(12):3691-3704. doi: 10.2337/db16-0248. Epub 2016 Sep 6. PMID: 27600065.

Giuliano L, Sofia V, Cardani R, Meola G, Zappia M. Drug resistant focal epilepsy in a patient with myotonic dystrophy type 2: casual or causal association? Neurol Sci. 2016 Nov;37(11):1867-1868. doi:10.1007/s10072-016-2619-5. Epub 2016 May 25. PMID: 27225277.

Guglielmi V, Oosterhof A, Voermans NC, Cardani R, Molenaar JP, van Kuppevelt TH, Meola G, van Engelen BG, Tomelleri G, Vattemi G. Characterization of sarcoplasmic reticulum Ca(2+) ATPase pumps in muscle of patients with myotonic dystrophy and with hypothyroid myopathy. Neuromuscul Disord. 2016 Jun;26(6):378-85. doi: 10.1016/j.nmd.2016.04.003. Epub 2016 Apr 6. PMID:27133661.

Valaperta R, Lombardi F, Cardani R, Fossati B, Brigonzi E, Merli I, Sansone V, Merletti G, Spina E, Meola G, Costa E. Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2. Genet Test Mol Biomarkers. 2015 Dec;19(12):703-9. doi: 10.1089/gtmb.2015.0135. Epub 2015 Oct 27. PMID: 26505324.

Iachettini S, Valaperta R, Marchesi A, Perfetti A, Cuomo G, Fossati B, Vaienti L, Costa E, Meola G, Cardani R. Tibialis anterior muscle needle biopsy and sensitive biomolecular methods: a useful tool in myotonic dystrophy type 1. Eur J Histochem. 2015 Oct 26;59(4):2562. doi: 10.4081/ejh.2015.2562. PMID:26708183; PMCID: PMC4698615.

Meola G, Cardani R. Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism. J Neuromuscul Dis. 2015 Jul 22;2(s2):S59-S71. doi: 10.3233/JND-150088. PMID: 27858759; PMCID: PMC5240594.

Bugiardini E, Rivolta I, Binda A, Soriano Caminero A, Cirillo F, Cinti A, Giovannoni R, Botta A, Cardani R, Wicklund MP, Meola G. SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotype. Neuromuscul Disord. 2015 Apr;25(4):301-7. doi: 10.1016/j.nmd.2015.01.006. Epub 2015 Jan 21. PMID:25660391.

Meola G, Cardani R. Myotonic dystrophies: An update on clinical aspects,genetic, pathology, and molecular pathomechanisms. Biochim Biophys Acta. 2015 Apr;1852(4):594-606. doi: 10.1016/j.bbadis.2014.05.019. Epub 2014 May 29. PMID:24882752.

Cardani R, Giagnacovo M, Rossi G, Renna LV, Bugiardini E, Pizzamiglio C, Botta A, Meola G. Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2. Neuromuscul Disord. 2014 Dec;24(12):1042-53. doi:10.1016/j.nmd.2014.06.435. Epub 2014 Jun 25. PMID: 25139674.

Renna LV, Cardani R, Botta A, Rossi G, Fossati B, Costa E, Meola G. Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction. Eur J Histochem. 2014 Oct 22;58(4):2444. doi: 10.4081/ejh.2014.2444. PMID: 25578974; PMCID: PMC4289846.

Malatesta M, Cardani R, Pellicciari C, Meola G. RNA Transcription and Maturation in Skeletal Muscle Cells are Similarly Impaired in Myotonic Dystrophy and Sarcopenia: The Ultrastructural Evidence. Front Aging Neurosci. 2014 Jul 30;6:196. doi: 10.3389/fnagi.2014.00196. PMID: 25126079; PMCID: PMC4115624.

Perfetti A, Greco S, Bugiardini E, Cardani R, Gaia P, Gaetano C, Meola G, Martelli F. Plasma microRNAs as biomarkers for myotonic dystrophy type 1. Neuromuscul Disord. 2014 Jun;24(6):509-15. doi: 10.1016/j.nmd.2014.02.005. Epub 2014 Feb 18. PMID: 24679513.

Perfetti A, Greco S, Fasanaro P, Bugiardini E, Cardani R, Garcia-Manteiga JM, Riba M, Cittaro D, Stupka E, Meola G, Martelli F. Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2. PLoS One. 2014 Apr 10;9(4):e93983. doi: 10.1371/journal.pone.0093983. Erratum in: PLoSOne. 2014;9(9):e108102. Manteiga, Jose M Garcia [corrected to Garcia-Manteiga, Jose M]. PMID: 24722564; PMCID: PMC3983107.

Cardani R, Giagnacovo M, Rossi G, Renna LV, Bugiardini E, Pizzamiglio C, Botta A, Meola G. Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2. Neuromuscul Disord. 2014 Dec;24(12):1042-53. doi: 10.1016/j.nmd.2014.06.435. Epub 2014 Jun 25. PubMed PMID: 25139674. IF. 2.64

Malatesta M, Cardani R, Pellicciari C, Meola G. RNA Transcription and Maturation in Skeletal Muscle Cells are Similarly Impaired in Myotonic Dystrophy and Sarcopenia: The Ultrastructural Evidence. Front Aging Neurosci. 2014 Jul 30;6:196. doi: 10.3389/fnagi.2014.00196. eCollection 2014. Review. PubMed PMID: 25126079; PubMed Central PMCID: PMC4115624. IF. 4.00.

Meola G, Cardani R. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms. Biochim Biophys Acta. 2015 Apr;1852(4):594-606. doi: 10.1016/j.bbadis.2014.05.019. Epub 2014 May 29. Review. PubMed PMID: 24882752. IF. 4.88

Perfetti A, Greco S, Fasanaro P, Bugiardini E, Cardani R, Manteiga JM, Riba M, Cittaro D, Stupka E, Meola G, Martelli F. Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2. PLoS One. 2014 Apr 10;9(4):e93983. doi: 10.1371/journal.pone.0093983. eCollection 2014. PubMed PMID: 24722564; PubMed Central PMCID: PMC3983107. IF. 3.23

Perfetti A, Greco S, Bugiardini E, Cardani R, Gaia P, Gaetano C, Meola G, Martelli F. Plasma microRNAs as biomarkers for myotonic dystrophy type 1. Neuromuscul Disord. 2014 Jun;24(6):509-15. doi: 10.1016/j.nmd.2014.02.005. Epub 2014 Feb 18. PubMed PMID: 24679513. IF. 2.64

Cardani R, Bugiardini E, Renna LV, Rossi G, Colombo G, Valaperta R, Novelli G, Botta A, Meola G. Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2. 2013 Dec 20;8(12):e83777. doi: 10.1371/journal.pone.0083777. eCollection 2013. PubMed PMID: 24376746; PubMed Central PMCID: PMC3869793. IF. 3.23

Malatesta M, Giagnacovo M, Costanzo M, Cisterna B, Cardani R, Meola G. Muscleblind-like1 undergoes ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia. Eur J Histochem. 2013 Apr 22;57(2):e15. doi: 10.4081/ejh.2013.e15. PubMed PMID: 23807294; PubMed Central PMCID: PMC3794341. . 2.04

Malatesta M, Giagnacovo M, Cardani R, Meola G, Pellicciari C. Human myoblasts from skeletal muscle biopsies: in vitro culture preparations for morphological and cytochemical analyses at light and electron microscopy. Methods Mol Biol. 2013;976:67-79. doi: 10.1007/978-1-62703-317-6_6. PubMed PMID: 23400435. IF. 1.29

Greco S, Perfetti A, Fasanaro P, Cardani R, Capogrossi MC, Meola G, Martelli F. Deregulated microRNAs in myotonic dystrophy type 2. PLoS One. 2012;7(6):e39732. doi: 10.1371/journal.pone.0039732. Epub 2012 Jun 29. PubMed PMID: 22768114; PubMed Central PMCID: PMC3387258. IF. 3.23

Giagnacovo M, Malatesta M, Cardani R, Meola G, Pellicciari C. Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2. Histochem Cell Biol. 2012 Oct;138(4):699-707. doi: 10.1007/s00418-012-0984-6. Epub 2012 Jun 17. PubMed PMID: 22706481. IF.3.05

Cardani R, Giagnacovo M, Botta A, Rinaldi F, Morgante A, Udd B, Raheem O, Penttilä S, Suominen T, Renna LV, Sansone V, Bugiardini E, Novelli G, Meola G. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2. J Neurol. 2012 Oct;259(10):2090-9. doi: 10.1007/s00415-012-6462-1. Epub 2012 Mar 10. PubMed PMID: 22407275. IF. 3.38

Malatesta M, Giagnacovo M, Renna LV, Cardani R, Meola G, Pellicciari C. Cultured myoblasts from patients affected by myotonic dystrophy type 2 exhibit senescence-related features: ultrastructural evidence. Eur J Histochem. 2011;55(3):e26. doi: 10.4081/ejh.2011.e26. Epub 2011 Aug 27. PubMed PMID: 22073373; PubMed Central PMCID: PMC3203470. IF. 2.04

Sicurelli F, Mignarri A, Cardani R, Mondelli M, Carluccio A, Marino D, Meola G, Federico A, Dotti MT. Myotonic dystrophy type 2 and autoimmune chronic gastritis: an incidental association? Neurol Sci. 2011 Dec;32(6):1249-50. doi: 10.1007/s10072-011-0782-2. Epub 2011 Sep 24. PubMed PMID: 21948056. IF. 1.45

Meola G, Bugiardini E, Cardani R. Muscle biopsy. J Neurol. 2012 Apr;259(4):601-10. doi: 10.1007/s00415-011-6193-8. Epub 2011 Jul 30. Review. PubMed PMID: 21805256. IF. 3.38.

Malatesta M, Giagnacovo M, Cardani R, Meola G, Pellicciari C. RNA processing is altered in skeletal muscle nuclei of patients affected by myotonic dystrophy. Histochem Cell Biol. 2011 Apr;135(4):419-25. doi: 10.1007/s00418-011-0797-z. Epub 2011 Mar 9. PubMed PMID: 21387185. IF.3.05

Perbellini R, Greco S, Sarra-Ferraris G, Cardani R, Capogrossi MC, Meola G, Martelli F. Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. Neuromuscul Disord. 2011 Feb;21(2):81-8. doi: 10.1016/j.nmd.2010.11.012. Epub 2010 Dec 18. PubMed PMID: 21169019. IF. 2.64

Giagnacovo M, Cardani R, Meola G, Pellicciari C, Malatesta M. Routinely frozen biopsies of human skeletal muscle are suitable for morphological and immunocytochemical analyses at transmission electron microscopy. Eur J Histochem. 2010 Jul 8;54(3):e31. PubMed PMID: 20819771; PubMed Central PMCID: PMC3167317. . 2.04

Rusconi F, Mancinelli E, Colombo G, Cardani R, Da Riva L, Bongarzone I, Meola G, Zippel R. Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways. Neurobiol Dis. 2010 May;38(2):273-80. doi: 10.1016/j.nbd.2010.01.017. Epub 2010 Feb 4. PubMed PMID: 20138216. IF. 5.08

Vihola A, Bachinski LL, Sirito M, Olufemi SE, Hajibashi S, Baggerly KA, Raheem O, Haapasalo H, Suominen T, Holmlund-Hampf J, Paetau A, Cardani R, Meola G, Kalimo H, Edström L, Krahe R, Udd B. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. Acta Neuropathol. 2010 Apr;119(4):465-79. doi: 10.1007/s00401-010-0637-6. Epub 2010 Jan 12. PubMed PMID: 20066428; PubMed Central PMCID: PMC4199327. IF.10.76

Perdoni F, Malatesta M, Cardani R, Giagnacovo M, Mancinelli E, Meola G, Pellicciari C. RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study. Eur J Histochem. 2009 Sep 23;53(3):151-8. PubMed PMID: 19864209. . IF. 2.04

Cardani R, Mancinelli E, Giagnacovo M, Sansone V, Meola G. Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies. Eur J Histochem. 2009 Apr-Jun;53(2):107-11. PubMed PMID: 19683984. . IF. 2.04

Greco S, De Simone M, Colussi C, Zaccagnini G, Fasanaro P, Pescatori M, Cardani R, Perbellini R, Isaia E, Sale P, Meola G, Capogrossi MC, Gaetano C, Martelli F. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J. 2009 Oct;23(10):3335-46. doi: 10.1096/fj.08-128579. Epub 2009 Jun 15. PubMed PMID: 19528256. IF. 5.04

Cardani R, Baldassa S, Botta A, Rinaldi F, Novelli G, Mancinelli E, Meola G. Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2. Neuromuscul Disord. 2009 May;19(5):335-43. doi: 10.1016/j.nmd.2009.03.002. Epub 2009 Apr 3. PubMed PMID: 19345584. IF. 2.64

Cardani R, Mancinelli E, Saino G, Bonavina L, Meola G. A putative role of ribonuclear inclusions and MBNL1 in the impairment of gallbladder smooth muscle contractility with cholelithiasis in myotonic dystrophy type 1. Neuromuscul Disord. 2008 Aug;18(8):641-5. doi: 10.1016/j.nmd.2008.06.366. Epub 2008 Jul 23. PubMed PMID: 18653337. IF. 2.64

Cardani R, Mancinelli E, Rotondo G, Sansone V, Meola G. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2. Eur J Histochem. 2006 Jul-Sep;50(3):177-82. PubMed PMID: 16920640. . IF. 2.04

La Porta CA, Cardani R, Facchetti F, Presicce P, Rao S, Privitera E, Clemente C, Mihm MC Jr. BRAF V599 E mutation occurs in Spitz and Reed naevi. J Eur Acad Dermatol Venereol. 2006 Oct;20(9):1164-5. PubMed PMID: 16987295. IF. 2.83

Cardani R, Zavanella T. Decreased density of beta1-adrenergic receptors in preneoplastic and neoplastic liver lesions of F344 rats. Histol Histopathol. 2005 Jul;20(3):843-50. PubMed PMID: 15944934. IF. 2.10

Cardani R, Mancinelli E, Sansone V, Rotondo G, Meola G. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur J Histochem. 2004 Oct-Dec;48(4):437-42. PubMed PMID: 15718211. IF. 2.04

Rotondo G, Sansone V, Cardani R, Mancinelli E, Krahe R, Stangalini D, Meola G. Proximal myotonic dystrophy mimicking progressive muscular atrophy. Eur J Neurol. 2005 Feb;12(2):160-1. PubMed PMID: 15679706. IF.4.05

Cedrola S, Cardani R, La Porta CA. Effect of glucose stress conditions in BL6T murine melanoma cells. Melanoma Res. 2004 Oct;14(5):345-51. PubMed PMID: 15457089. IF 2.28.

Cardani R, Zavanella T. Immunohistochemical localization of beta 1-adrenergic receptors in the liver of male and female F344 rat. Histochem Cell Biol. 2001 Nov;116(5):441-5. Epub 2001 Nov 1. PubMed PMID: 11735007. 3.05

Cardani R, Zavanella T. Age-related cell proliferation and apoptosis in the kidney of male Fischer 344 rats with observations on a spontaneous tubular cell adenoma. Toxicol Pathol. 2000 Nov-Dec;28(6):802-6. PubMed PMID: 11127294. IF. 2.14

Cardani R, Ragnotti G, Radaelli G, Zavanella T. Influence of beta-adrenergic antagonists on cell proliferation rates in the kidney of untreated and diethylnitrosamine-treated male F344 rats. Chem Biol Interact. 1999 Apr 15;118(3):217-31. PubMed PMID: 10362228. IF. 2.58